Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan

AIMS/INTRODUCTION: Large‐scale clinical trials have reported that, in patients with type 2 diabetes mellitus, sodium–glucose cotransporter 2 (SGLT2) inhibitor treatment affords favorable renal outcomes; the underlying mechanisms, however, remain unclear. Thus, this study investigated how SGLT2 inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuo, Toyoda, Masao, Hatori, Nobuo, Furuki, Takayuki, Sakai, Hiroyuki, Sato, Kazuyoshi, Miyakawa, Masaaki, Tamura, Kouichi, Kanamori, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354503/
https://www.ncbi.nlm.nih.gov/pubmed/33377605
http://dx.doi.org/10.1111/jdi.13491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354503/
https://www.ncbi.nlm.nih.gov/pubmed/33377605
http://dx.doi.org/10.1111/jdi.13491

Ejemplares similares